David Murphy
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 29 | 2026 | 924 | 5.030 |
Why?
| | Critical Care | 12 | 2026 | 702 | 2.790 |
Why?
| | Critical Illness | 15 | 2026 | 899 | 2.230 |
Why?
| | Erythrocyte Transfusion | 6 | 2019 | 225 | 1.960 |
Why?
| | Organ Dysfunction Scores | 4 | 2023 | 55 | 1.460 |
Why?
| | Health Resources | 3 | 2016 | 130 | 1.240 |
Why?
| | Hospital Mortality | 13 | 2026 | 1038 | 1.070 |
Why?
| | Quality Indicators, Health Care | 3 | 2026 | 336 | 1.030 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2018 | 58 | 0.990 |
Why?
| | Delphi Technique | 3 | 2025 | 330 | 0.910 |
Why?
| | Sepsis | 8 | 2024 | 662 | 0.870 |
Why?
| | Common Data Elements | 1 | 2025 | 18 | 0.870 |
Why?
| | Quality Improvement | 4 | 2026 | 1293 | 0.840 |
Why?
| | Neurodevelopmental Disorders | 5 | 2026 | 226 | 0.840 |
Why?
| | Cross Infection | 3 | 2019 | 260 | 0.790 |
Why?
| | Wounds and Injuries | 3 | 2025 | 960 | 0.790 |
Why?
| | Multiple Organ Failure | 3 | 2019 | 120 | 0.740 |
Why?
| | Brain Diseases | 4 | 2024 | 154 | 0.710 |
Why?
| | Computed Tomography Angiography | 3 | 2017 | 146 | 0.680 |
Why?
| | Fluid Therapy | 3 | 2024 | 154 | 0.680 |
Why?
| | Bacterial Infections | 2 | 2021 | 246 | 0.640 |
Why?
| | Radiation Dosage | 2 | 2020 | 193 | 0.600 |
Why?
| | Humans | 88 | 2026 | 145140 | 0.600 |
Why?
| | Health Care Costs | 3 | 2020 | 425 | 0.600 |
Why?
| | Survivors | 1 | 2023 | 522 | 0.580 |
Why?
| | Movement Disorders | 3 | 2024 | 69 | 0.570 |
Why?
| | Coronary Angiography | 3 | 2017 | 328 | 0.570 |
Why?
| | Coronary Artery Disease | 4 | 2019 | 747 | 0.560 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 77 | 0.560 |
Why?
| | Systemic Inflammatory Response Syndrome | 2 | 2022 | 95 | 0.550 |
Why?
| | Ventilators, Mechanical | 2 | 2020 | 71 | 0.520 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2017 | 38 | 0.520 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 68 | 0.500 |
Why?
| | Mitral Valve | 1 | 2017 | 95 | 0.500 |
Why?
| | Respiration, Artificial | 4 | 2026 | 713 | 0.500 |
Why?
| | Hip Fractures | 1 | 2018 | 87 | 0.500 |
Why?
| | Phenotype | 12 | 2026 | 3138 | 0.500 |
Why?
| | Hemoglobins | 6 | 2019 | 386 | 0.490 |
Why?
| | Blood Transfusion | 2 | 2018 | 407 | 0.480 |
Why?
| | Intellectual Disability | 5 | 2026 | 178 | 0.480 |
Why?
| | Practice Patterns, Physicians' | 3 | 2021 | 1365 | 0.480 |
Why?
| | Physician Incentive Plans | 1 | 2016 | 8 | 0.470 |
Why?
| | United States Public Health Service | 1 | 2015 | 9 | 0.470 |
Why?
| | Albumins | 1 | 2016 | 119 | 0.460 |
Why?
| | Pneumonia, Viral | 4 | 2020 | 388 | 0.450 |
Why?
| | Middle Aged | 33 | 2026 | 36126 | 0.440 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2017 | 198 | 0.440 |
Why?
| | Hospitals | 2 | 2020 | 732 | 0.430 |
Why?
| | Radiology | 1 | 2017 | 174 | 0.420 |
Why?
| | Emergencies | 1 | 2015 | 174 | 0.420 |
Why?
| | Lung Diseases | 2 | 2024 | 780 | 0.410 |
Why?
| | Female | 43 | 2026 | 78636 | 0.400 |
Why?
| | Cardiac Catheterization | 1 | 2017 | 558 | 0.400 |
Why?
| | Cardiomyopathies | 1 | 2017 | 335 | 0.390 |
Why?
| | Developmental Disabilities | 3 | 2024 | 281 | 0.380 |
Why?
| | Male | 41 | 2026 | 72664 | 0.380 |
Why?
| | Guideline Adherence | 3 | 2016 | 586 | 0.380 |
Why?
| | Spastic Paraplegia, Hereditary | 2 | 2022 | 12 | 0.370 |
Why?
| | Catheter-Related Infections | 2 | 2010 | 96 | 0.370 |
Why?
| | Microcephaly | 2 | 2024 | 104 | 0.360 |
Why?
| | Data Collection | 1 | 2015 | 639 | 0.360 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 739 | 0.360 |
Why?
| | Retrospective Studies | 19 | 2026 | 17247 | 0.350 |
Why?
| | Emergency Medical Services | 2 | 2016 | 684 | 0.350 |
Why?
| | Aged | 24 | 2026 | 26096 | 0.350 |
Why?
| | Catheterization, Central Venous | 2 | 2010 | 123 | 0.350 |
Why?
| | Evidence-Based Practice | 1 | 2014 | 231 | 0.350 |
Why?
| | APACHE | 4 | 2026 | 68 | 0.340 |
Why?
| | Coronavirus Infections | 3 | 2020 | 382 | 0.330 |
Why?
| | Mitochondrial Diseases | 2 | 2022 | 92 | 0.330 |
Why?
| | Hospitalization | 7 | 2022 | 2458 | 0.330 |
Why?
| | Societies, Hospital | 1 | 2010 | 1 | 0.320 |
Why?
| | Consensus | 3 | 2025 | 478 | 0.320 |
Why?
| | Water-Electrolyte Imbalance | 2 | 2025 | 42 | 0.320 |
Why?
| | Severity of Illness Index | 6 | 2026 | 2928 | 0.320 |
Why?
| | Tomography, X-Ray Computed | 4 | 2024 | 2767 | 0.310 |
Why?
| | Aged, 80 and over | 9 | 2021 | 8318 | 0.300 |
Why?
| | Epilepsy | 2 | 2023 | 390 | 0.270 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2009 | 98 | 0.270 |
Why?
| | Delivery of Health Care | 1 | 2015 | 946 | 0.270 |
Why?
| | Adult | 21 | 2025 | 40665 | 0.260 |
Why?
| | Betacoronavirus | 2 | 2020 | 287 | 0.260 |
Why?
| | Machine Learning | 4 | 2026 | 586 | 0.260 |
Why?
| | Hospital Costs | 2 | 2019 | 125 | 0.250 |
Why?
| | Maryland | 2 | 2018 | 67 | 0.230 |
Why?
| | Parkinsonian Disorders | 1 | 2026 | 43 | 0.230 |
Why?
| | Acute Lung Injury | 1 | 2009 | 305 | 0.230 |
Why?
| | Genetic Heterogeneity | 1 | 2026 | 65 | 0.230 |
Why?
| | Electronic Health Records | 5 | 2024 | 1188 | 0.230 |
Why?
| | Catechol O-Methyltransferase | 1 | 2025 | 20 | 0.230 |
Why?
| | Mediator Complex | 2 | 2023 | 61 | 0.220 |
Why?
| | Quality of Health Care | 3 | 2021 | 692 | 0.220 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2026 | 155 | 0.220 |
Why?
| | Length of Stay | 3 | 2025 | 1348 | 0.220 |
Why?
| | United States | 15 | 2021 | 16065 | 0.220 |
Why?
| | Unsupervised Machine Learning | 1 | 2025 | 23 | 0.220 |
Why?
| | Pneumonia | 2 | 2010 | 635 | 0.210 |
Why?
| | Medication Therapy Management | 1 | 2025 | 72 | 0.210 |
Why?
| | Mutation | 9 | 2026 | 4071 | 0.210 |
Why?
| | Infection Control | 3 | 2018 | 173 | 0.210 |
Why?
| | Patient Satisfaction | 1 | 2009 | 708 | 0.210 |
Why?
| | Coronary Vessels | 2 | 2016 | 246 | 0.200 |
Why?
| | Congenital Disorders of Glycosylation | 1 | 2023 | 17 | 0.200 |
Why?
| | Epilepsy, Generalized | 1 | 2023 | 22 | 0.200 |
Why?
| | Nervous System Malformations | 1 | 2024 | 46 | 0.200 |
Why?
| | Cysts | 1 | 2024 | 112 | 0.200 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 101 | 0.200 |
Why?
| | Prognosis | 3 | 2023 | 4310 | 0.200 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 90 | 0.200 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2023 | 45 | 0.200 |
Why?
| | Membrane Transport Proteins | 1 | 2024 | 153 | 0.190 |
Why?
| | Resuscitation | 2 | 2024 | 310 | 0.190 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2024 | 148 | 0.190 |
Why?
| | Systems Analysis | 1 | 2023 | 22 | 0.190 |
Why?
| | Positron Emission Tomography Computed Tomography | 3 | 2024 | 117 | 0.190 |
Why?
| | Abnormalities, Multiple | 1 | 2024 | 197 | 0.190 |
Why?
| | Cell Division | 1 | 2024 | 753 | 0.190 |
Why?
| | Child, Preschool | 11 | 2026 | 11835 | 0.190 |
Why?
| | Information Dissemination | 1 | 2025 | 224 | 0.190 |
Why?
| | Dystonia | 1 | 2022 | 27 | 0.190 |
Why?
| | Neural Stem Cells | 1 | 2024 | 168 | 0.180 |
Why?
| | Pandemics | 5 | 2021 | 1703 | 0.180 |
Why?
| | Pharmacists | 2 | 2022 | 258 | 0.180 |
Why?
| | Hearing Loss | 1 | 2026 | 249 | 0.180 |
Why?
| | Apyrase | 1 | 2022 | 27 | 0.180 |
Why?
| | Parkinson Disease | 2 | 2026 | 599 | 0.180 |
Why?
| | Patient Safety | 1 | 2026 | 355 | 0.180 |
Why?
| | Pedigree | 4 | 2026 | 515 | 0.180 |
Why?
| | Connective Tissue Diseases | 1 | 2022 | 85 | 0.180 |
Why?
| | beta Karyopherins | 1 | 2021 | 9 | 0.170 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 272 | 0.170 |
Why?
| | Community Pharmacy Services | 1 | 2021 | 46 | 0.170 |
Why?
| | Pharmacy | 1 | 2021 | 32 | 0.170 |
Why?
| | Resource Allocation | 1 | 2021 | 52 | 0.170 |
Why?
| | ROC Curve | 1 | 2023 | 617 | 0.170 |
Why?
| | Loss of Heterozygosity | 1 | 2021 | 52 | 0.170 |
Why?
| | Loss of Function Mutation | 1 | 2021 | 45 | 0.170 |
Why?
| | Infant | 9 | 2026 | 10060 | 0.170 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 221 | 0.170 |
Why?
| | Pharmaceutical Services | 1 | 2021 | 76 | 0.170 |
Why?
| | Cataract | 1 | 2023 | 238 | 0.160 |
Why?
| | Cannula | 1 | 2020 | 28 | 0.160 |
Why?
| | Health Care Surveys | 2 | 2014 | 535 | 0.160 |
Why?
| | Pharmacy Service, Hospital | 1 | 2021 | 89 | 0.160 |
Why?
| | Pneumonia, Bacterial | 1 | 2021 | 113 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 140 | 0.160 |
Why?
| | Retinal Diseases | 1 | 2021 | 101 | 0.160 |
Why?
| | Genetic Predisposition to Disease | 2 | 2026 | 2351 | 0.160 |
Why?
| | White Matter | 1 | 2022 | 152 | 0.160 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 302 | 0.150 |
Why?
| | Immunomodulation | 1 | 2020 | 99 | 0.150 |
Why?
| | Coinfection | 1 | 2021 | 143 | 0.150 |
Why?
| | Medical Overuse | 1 | 2020 | 30 | 0.150 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2019 | 30 | 0.150 |
Why?
| | DNA, Mitochondrial | 1 | 2021 | 211 | 0.150 |
Why?
| | Urinalysis | 1 | 2020 | 83 | 0.150 |
Why?
| | Quality Assurance, Health Care | 3 | 2010 | 342 | 0.150 |
Why?
| | Hematocrit | 1 | 2019 | 108 | 0.150 |
Why?
| | DNA Methylation | 1 | 2024 | 667 | 0.150 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2021 | 138 | 0.150 |
Why?
| | Nuclear Proteins | 1 | 2024 | 738 | 0.150 |
Why?
| | Socioenvironmental Therapy | 1 | 2019 | 2 | 0.150 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2019 | 71 | 0.150 |
Why?
| | Health Equity | 1 | 2021 | 133 | 0.140 |
Why?
| | Syndrome | 3 | 2026 | 380 | 0.140 |
Why?
| | Economics, Hospital | 1 | 2019 | 28 | 0.140 |
Why?
| | Cohort Studies | 6 | 2026 | 5988 | 0.140 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2020 | 181 | 0.140 |
Why?
| | Weight Loss | 1 | 2024 | 845 | 0.140 |
Why?
| | Diagnostic Techniques and Procedures | 1 | 2018 | 19 | 0.140 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 138 | 0.140 |
Why?
| | Academic Medical Centers | 3 | 2022 | 552 | 0.140 |
Why?
| | New Jersey | 1 | 2018 | 16 | 0.140 |
Why?
| | Clinical Protocols | 2 | 2017 | 280 | 0.140 |
Why?
| | Adolescent | 11 | 2026 | 22479 | 0.140 |
Why?
| | Kentucky | 1 | 2018 | 43 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2023 | 381 | 0.140 |
Why?
| | Nutrition Assessment | 1 | 2018 | 90 | 0.140 |
Why?
| | Medical Audit | 2 | 2017 | 77 | 0.130 |
Why?
| | Bacteremia | 2 | 2010 | 222 | 0.130 |
Why?
| | Anemia | 1 | 2019 | 190 | 0.130 |
Why?
| | Nervous System Diseases | 1 | 2021 | 286 | 0.130 |
Why?
| | Plasma | 1 | 2019 | 223 | 0.130 |
Why?
| | Acute Coronary Syndrome | 2 | 2019 | 297 | 0.130 |
Why?
| | Intubation, Intratracheal | 1 | 2020 | 325 | 0.130 |
Why?
| | Washington | 1 | 2018 | 149 | 0.130 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 168 | 0.130 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 362 | 0.130 |
Why?
| | Urinary Tract Infections | 1 | 2020 | 210 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2024 | 1742 | 0.130 |
Why?
| | Hospitals, University | 1 | 2017 | 176 | 0.130 |
Why?
| | Preoperative Period | 1 | 2017 | 149 | 0.130 |
Why?
| | Shock, Hemorrhagic | 1 | 2019 | 199 | 0.130 |
Why?
| | Child | 10 | 2026 | 22670 | 0.120 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2016 | 21 | 0.120 |
Why?
| | Prospective Studies | 4 | 2016 | 8035 | 0.120 |
Why?
| | Risk Factors | 5 | 2021 | 10857 | 0.120 |
Why?
| | Drug Utilization Review | 1 | 2016 | 61 | 0.120 |
Why?
| | Arteritis | 1 | 2016 | 23 | 0.120 |
Why?
| | Cost Savings | 1 | 2016 | 86 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2019 | 265 | 0.120 |
Why?
| | Residence Characteristics | 1 | 2019 | 373 | 0.120 |
Why?
| | Zebrafish | 3 | 2026 | 532 | 0.110 |
Why?
| | Fracture Fixation, Internal | 1 | 2018 | 213 | 0.110 |
Why?
| | Heart Neoplasms | 1 | 2015 | 56 | 0.110 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2018 | 182 | 0.110 |
Why?
| | Respiratory Insufficiency | 2 | 2020 | 326 | 0.110 |
Why?
| | Patient Outcome Assessment | 1 | 2015 | 130 | 0.110 |
Why?
| | Burns | 1 | 2019 | 374 | 0.110 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 200 | 0.100 |
Why?
| | Baltimore | 1 | 2014 | 72 | 0.100 |
Why?
| | Shock | 1 | 2015 | 109 | 0.100 |
Why?
| | Regression Analysis | 1 | 2016 | 998 | 0.100 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1579 | 0.100 |
Why?
| | Medical Staff, Hospital | 1 | 2014 | 80 | 0.100 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 279 | 0.100 |
Why?
| | Drosophila melanogaster | 2 | 2026 | 236 | 0.100 |
Why?
| | Time Factors | 3 | 2022 | 7107 | 0.100 |
Why?
| | Brain Injuries, Traumatic | 1 | 2019 | 453 | 0.100 |
Why?
| | Injury Severity Score | 1 | 2015 | 599 | 0.100 |
Why?
| | Animals | 9 | 2026 | 37952 | 0.100 |
Why?
| | Carcinoma, Renal Cell | 1 | 2015 | 230 | 0.100 |
Why?
| | Confidence Intervals | 1 | 2013 | 330 | 0.090 |
Why?
| | Age Factors | 2 | 2017 | 3338 | 0.090 |
Why?
| | Acidosis | 1 | 2013 | 105 | 0.090 |
Why?
| | Organizational Culture | 2 | 2010 | 161 | 0.090 |
Why?
| | Paraplegia | 2 | 2022 | 60 | 0.090 |
Why?
| | Nursing Staff, Hospital | 1 | 2014 | 143 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2016 | 468 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2016 | 887 | 0.090 |
Why?
| | Anti-Bacterial Agents | 2 | 2020 | 1922 | 0.090 |
Why?
| | Program Evaluation | 1 | 2016 | 943 | 0.080 |
Why?
| | Kidney Neoplasms | 1 | 2015 | 412 | 0.080 |
Why?
| | Young Adult | 6 | 2025 | 14176 | 0.080 |
Why?
| | Patient Discharge | 1 | 2018 | 991 | 0.080 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2013 | 288 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2020 | 11741 | 0.080 |
Why?
| | Obesity | 1 | 2024 | 3097 | 0.080 |
Why?
| | Odds Ratio | 1 | 2013 | 1082 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4552 | 0.080 |
Why?
| | Diet | 1 | 2018 | 1277 | 0.080 |
Why?
| | Checklist | 1 | 2010 | 110 | 0.070 |
Why?
| | Fibroblasts | 2 | 2026 | 1022 | 0.070 |
Why?
| | Safety Management | 1 | 2010 | 125 | 0.070 |
Why?
| | Medical Errors | 1 | 2009 | 119 | 0.070 |
Why?
| | Cardiac Surgical Procedures | 1 | 2014 | 608 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 391 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1415 | 0.070 |
Why?
| | Mitochondria | 2 | 2026 | 992 | 0.060 |
Why?
| | Lung | 1 | 2020 | 4101 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2183 | 0.060 |
Why?
| | Brain | 3 | 2024 | 2934 | 0.060 |
Why?
| | Workload | 1 | 2009 | 168 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2024 | 1163 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4282 | 0.060 |
Why?
| | Decision Making | 1 | 2014 | 974 | 0.060 |
Why?
| | Mice | 4 | 2026 | 18303 | 0.060 |
Why?
| | Connexin 26 | 1 | 2026 | 9 | 0.060 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2026 | 74 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2949 | 0.060 |
Why?
| | Oregon | 1 | 2025 | 76 | 0.060 |
Why?
| | North Carolina | 1 | 2025 | 129 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2017 | 2377 | 0.060 |
Why?
| | Anti-Inflammatory Agents | 1 | 2008 | 477 | 0.050 |
Why?
| | Ethanolamine | 1 | 2024 | 6 | 0.050 |
Why?
| | Birt-Hogg-Dube Syndrome | 1 | 2024 | 8 | 0.050 |
Why?
| | Genes, Dominant | 1 | 2024 | 100 | 0.050 |
Why?
| | Genes, Recessive | 1 | 2024 | 78 | 0.050 |
Why?
| | N-Terminal Acetyltransferase F | 1 | 2024 | 1 | 0.050 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2024 | 5 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2008 | 531 | 0.050 |
Why?
| | Proof of Concept Study | 1 | 2024 | 89 | 0.050 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2024 | 36 | 0.050 |
Why?
| | Lymphangioleiomyomatosis | 1 | 2024 | 37 | 0.050 |
Why?
| | Receptors, Virus | 1 | 2024 | 95 | 0.050 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2024 | 63 | 0.050 |
Why?
| | Inheritance Patterns | 1 | 2024 | 44 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2024 | 132 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2024 | 316 | 0.050 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 161 | 0.050 |
Why?
| | Cell Polarity | 1 | 2024 | 137 | 0.050 |
Why?
| | Choline | 1 | 2024 | 137 | 0.050 |
Why?
| | Tremor | 1 | 2024 | 98 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2024 | 117 | 0.050 |
Why?
| | Acetylation | 1 | 2024 | 259 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 374 | 0.050 |
Why?
| | Atrophy | 1 | 2023 | 198 | 0.050 |
Why?
| | Glycosylation | 1 | 2023 | 173 | 0.050 |
Why?
| | Phosphates | 1 | 2024 | 177 | 0.050 |
Why?
| | Drosophila Proteins | 1 | 2025 | 212 | 0.050 |
Why?
| | Vesicular Monoamine Transport Proteins | 1 | 2022 | 9 | 0.050 |
Why?
| | Spectrin | 1 | 2022 | 14 | 0.050 |
Why?
| | Neurogenesis | 1 | 2024 | 157 | 0.050 |
Why?
| | Amines | 1 | 2022 | 39 | 0.050 |
Why?
| | Dysarthria | 1 | 2022 | 10 | 0.050 |
Why?
| | Ataxia | 1 | 2022 | 69 | 0.050 |
Why?
| | Nervous System | 1 | 2022 | 69 | 0.040 |
Why?
| | Homozygote | 1 | 2022 | 199 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2022 | 133 | 0.040 |
Why?
| | Cerebellum | 1 | 2023 | 224 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2023 | 500 | 0.040 |
Why?
| | Alleles | 1 | 2024 | 888 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2021 | 5411 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2024 | 429 | 0.040 |
Why?
| | Mortality | 2 | 2017 | 378 | 0.040 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 919 | 0.040 |
Why?
| | Time | 1 | 2020 | 84 | 0.040 |
Why?
| | Georgia | 1 | 2020 | 79 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2020 | 140 | 0.040 |
Why?
| | Radiotherapy Dosage | 1 | 2020 | 288 | 0.040 |
Why?
| | Pyuria | 1 | 2020 | 5 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2022 | 263 | 0.040 |
Why?
| | Disease Management | 1 | 2024 | 651 | 0.040 |
Why?
| | Professional Role | 1 | 2021 | 169 | 0.040 |
Why?
| | Morbidity | 1 | 2021 | 322 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2024 | 1506 | 0.040 |
Why?
| | Catheters, Indwelling | 2 | 2010 | 96 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 672 | 0.040 |
Why?
| | Inappropriate Prescribing | 1 | 2020 | 66 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2022 | 326 | 0.040 |
Why?
| | Safety | 1 | 2020 | 357 | 0.040 |
Why?
| | Homeostasis | 1 | 2022 | 639 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2021 | 474 | 0.030 |
Why?
| | Seizures | 1 | 2022 | 482 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2022 | 572 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2136 | 0.030 |
Why?
| | Lung Diseases, Interstitial | 1 | 2024 | 659 | 0.030 |
Why?
| | Insurance Claim Reporting | 1 | 2017 | 26 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2025 | 3616 | 0.030 |
Why?
| | Clinical Coding | 1 | 2017 | 27 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2026 | 1993 | 0.030 |
Why?
| | Education, Distance | 1 | 2018 | 59 | 0.030 |
Why?
| | Societies, Medical | 1 | 2021 | 898 | 0.030 |
Why?
| | RNA | 1 | 2022 | 910 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1321 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 2087 | 0.030 |
Why?
| | Population Surveillance | 1 | 2019 | 484 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1657 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2020 | 1058 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 6055 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2018 | 907 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3114 | 0.030 |
Why?
| | Rats | 1 | 2022 | 5582 | 0.030 |
Why?
| | Coronary Artery Bypass | 1 | 2016 | 268 | 0.030 |
Why?
| | Research Design | 1 | 2018 | 1132 | 0.020 |
Why?
| | Algorithms | 1 | 2020 | 1845 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2855 | 0.020 |
Why?
| | Hospital Administration | 1 | 2010 | 26 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2915 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3410 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2115 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5972 | 0.020 |
Why?
| | Inservice Training | 1 | 2010 | 118 | 0.020 |
Why?
| | Problem Solving | 1 | 2010 | 156 | 0.020 |
Why?
| | Program Development | 1 | 2010 | 368 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5208 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2010 | 461 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2008 | 571 | 0.020 |
Why?
| | Leadership | 1 | 2010 | 400 | 0.010 |
Why?
| | Risk | 1 | 2008 | 916 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5886 | 0.010 |
Why?
| | Patient Care Team | 1 | 2010 | 696 | 0.010 |
Why?
| | Fractures, Bone | 1 | 2008 | 426 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2013 | 6435 | 0.010 |
Why?
|
|
Murphy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|